Mayne Pharma Starts Construction on $65 Million Facility for Pharmaceutical Manufacturing

Mayne Pharma (ASK:MYX) has begun construction on a brand new pharmaceutical manufacturing facility, anticipated to cost $65 million.
According to Pharmaceutical Processing:

At an event today marking the start of construction on a new $65-million pharmaceutical manufacturing facility, Mayne Pharma shared additional details about the 126,000-square-foot oral-dose facility in Greenville, N.C. The new facility will double the company’s U.S. manufacturing capacity and introduce commercial-scale fluid-bed processing capacity for modified-release bead/pellet drugs. Space within the company’s existing facility will be repurposed to expand contract analytical and formulation development services offered by Metrics Contract Services.
The $65-million strategic investment will fund:

• A new, greenfield 126,000-square-foot, oral-dose commercial manufacturing facility adjacent to the company’s existing building. The new facility will more than double Mayne Pharma’s U.S. manufacturing capacity to support and accelerate organic growth

• The re-purposing of space within the existing facility, significantly expanding contract analytical laboratory and formulation development services capacity

• A new visitor and staff administrative center linking the two main buildings

Click here to read the full article on Pharmaceutical Processing.